Shire Joins Illinois Biotechnology Innovation Organization as Leadership Sponsor and Adds Shannon Resetich to the Board

CHICAGO--()--The Illinois Biotechnology Innovation Organization—better known as iBIO®– today announced that through its growing support, Shire has been elevated to an iBIO Leadership Sponsor. Leadership sponsors of iBIO are recognized publicly as being the lead investors in the future of science innovation and commercialization in Illinois.

As further evidence of iBIO’s strong membership and leadership growth, earlier this year Shannon Resetich, Global Franchise Head of Hematology at Shire was elected to join the iBIO Board of Directors. Shannon is responsible for leading Shire's Hematology franchise. Her focus is on meeting the needs of patients with rare hematologic conditions, such as hemophilia and von Willebrand disease, and sustaining and growing Shire's global leadership position in the Hematology space.

“Shire is proud to be an iBIO Leadership Sponsor and supports the great work iBIO does to build Illinois and the surrounding Midwest into a leading life sciences community,” said Shannon Resetich, Global Franchise Head, Hematology, Shire. “I am honored to join the Board and I look forward to engaging in the iBIO community.”

iBIO President & CEO Warren Ribley added: “We are honored to have Shire as a leadership sponsor. Their investment and leadership in iBIO will help us continue growth of our life science and medical technology community.”

Shire joins a prestigious group including AbbVie, Astellas US, Horizon Pharma and Takeda Pharmaceuticals America as other iBIO Leadership Sponsors.

About the Illinois Biotechnology Innovation Organization

iBIO’s mission is to make Illinois and the surrounding Midwest one of the world’s top life sciences centers: a great place to do business and a great place to grow technology ventures.

iBIO, working on its own and through valued partners

  • Promotes sound public policy at the local, state and federal levels;
  • Improves our region’s ability to create, attract and retain businesses
  • Orchestrates industry involvement to help solve America’s math and science education crisis
  • Builds community by providing opportunities to connect and engage with the industry

We thereby contribute to the well-being of people worldwide while creating new jobs, attracting firms to the region and generating prosperity.

iBIO’s Leadership Sponsors are AbbVie, Astellas US, Horizon Pharma, Shire and Takeda Pharmaceuticals America.

About Shire

Shire is the leading global biotechnology company focused on serving people with rare diseases and other highly specialized conditions. We strive to develop best-in-class products, many of which are available in more than 100 countries, across core therapeutic areas including Hematology, Immunology, Neuroscience, Ophthalmics, Lysosomal Storage Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary Angioedema; and a growing franchise in Oncology.

Our employees come to work every day with a shared mission: to develop and deliver breakthrough therapies for the hundreds of millions of people in the world affected by rare diseases and other high-need conditions, and who lack effective therapies to live their lives to the fullest.

www.shire.com

Contacts

iBIO
John Conrad, 312-422-1111
jconrad@ibio.org
www.ibio.org

Contacts

iBIO
John Conrad, 312-422-1111
jconrad@ibio.org
www.ibio.org